Exclusive interview with Dr Charlie Weller
Here at the World Vaccine Congress, we are looking forward to our next event in Barcelona in October 2022. Speaking at the Congress will be Dr Charlie Weller, Head of Prevention, Infectious Disease at the Wellcome Trust. We caught up with her about what we can expect...
WHO announces 2023 influenza vaccine recommendation
In September 2022 the WHO announced its recommendation for the viral composition of influenza vaccines for the 2023 southern hemisphere influenza season. These recommendations inform the development, production, and licensing of influenza vaccines by regulatory...
Immune imprinting: a help or a hindrance?
In an interview for the Human Vaccines Project in September 2022, Kristen Jill Abboud spoke to Professor Deepta Bhattacharya
MOST POPULAR THIS MONTH
Exclusive interview with Dr Miguel Sanjuan
With just a few weeks left until the World Vaccine Congress in Europe 2022 we are looking forward to hearing from a range of incredible speakers. One such speaker is Dr Miguel Sanjuan, SVP Research and Development at Provention Bio. He will be showcasing a vaccine...
Sabin announces further BARDA funding for trials
In September 2022 the Sabin Vaccine Institute announced that it was “receiving an additional $21.8 million” from the Biomedical Advanced Research and Development Authority (BARDA) in the US. These funds, part of an existing contract, “advance development of a vaccine...
Long Covid: more questions than answers, studies suggest
An article by Gavi in September 2022 explored the few studies that investigate the links between COVID-19 vaccination and Long Covid. WHO’s Dr Janet Diaz described the many possible symptoms of “post COVID-19 condition” or Long Covid, identifying more than 200...
Global Fund Partners announce record funding against disease
In September 2022 the US hosted a “pledging conference” for the Global Fund to Fight AIDS, Tuberculosis, and Malaria. This raised a total of more than $14.25 billion for work over the coming 3 years. The conference united 45 countries as well as private sector...
Uganda declares Ebola outbreak of ‘Sudan’ strain
In September 2022 the WHO announced that health authorities in Uganda had declared an outbreak of Ebola. This follows a case of the Sudan ebolavirus in the Mubende district. Ebola is described by the WHO as a “severe, often fatal illness” in humans and other primates....
CEPI launches funding for Rift Valley fever trials
In September 2022 CEPI announced the launch of its second phase of funding to “advance innovative Rift Valley fever vaccine programmes into clinical trials”. The funding, which includes $35 million in financial support from the EU Horizon Europe programme, reaches a...
White paper from SGS: vaccine development post-pandemic
In a white paper from SGS in September 2022 the importance of “analytical biosafety testing” and “advances in developing scientific technologies” was emphasised as crucial in preparing for the “next pandemic”. The paper reflects that before the COVID-19 pandemic, the...
European biotechs receive EUREKA therapeutic funding
In September 2022 LABIOTECH.EU announced that a partnership between European biotech companies had been awarded a €1.06 million grant from EUREKA Eurostars. CimCure BV, a Dutch Biotech, Covalab, a French biotech, Amsterdam UMC, and the University of Zurich have...
LATEST
Fauci’s warning: politics disrupts childhood immunisation
Dr Anthony Fauci warned that tension caused by the politicisation of the COVID-19 vaccination programme could affect routine childhood immunisations.
Biden declares pandemic over, sends shares plummeting
In September 2022 Biden declared in a 60 Minutes broadcast that the “pandemic is over”. Despite acknowledging that “we still have a problem” with COVID-19
Marking WHO’s World Patient Safety Day 2022
On September 17th the WHO marks World Patient Safety Day: safe maternal and new-born care. The World Health Assembly established World Patient Safety Day
mRNA giants launch therapeutic protein ambitions
Published in Nature in September 2022, Ken Garber explores the hopes of mRNA companies who are setting their sights back on therapeutic proteins.
Holding out hope: a therapeutic prostate cancer vaccine
In Nature in September 2022 an article by Anthony King identified the difficulties associated with creating an immunotherapy for prostate tumours
World Vaccine Congress Europe 2022: meet our start-ups!
In its 23rd year the World Vaccine Congress Europe is set to be one of our biggest and most exciting events. We will be bringing experts from the value chain
VIDEOS
World Vaccine Congress Europe 2022: meet our exhibitors!
We hope you are looking forward to our World Vaccine Congress in Barcelona, 2022; we certainly are! We are pleased to tease some of the amazing exhibitors who will be in attendance in this short video. If you are interested in learning more about exhibiting then...
World Vaccine Congress Europe 2022: meet our sponsors!
Here at the World Vaccine Congress we are looking forward to meeting everyone at our Congress in Barcelona, October 2022. To introduce some the sponsors we have lined up already we are pleased to share this short video of our sponsors. If you are interested in...
World Vaccine Congress Europe 2022 trailer!
We are thrilled to share this short video teasing the World Vaccine Congress in Europe, 2022! To get your tickets click here.
World Vaccine Congress 2022 Washington reel!
Check out this video from our World Vaccine Congress 2022!
World Vaccine Congress 2020 invitation!
This short video features an invitation to the World Vaccine Congress in Europe, 2020. We are already preparing for the 2022 World Vaccine Congress
World Vaccine Congress Washington 2019 trailer!
This short video shows our previous World Vaccine Congress in Washington, 2019. We are already preparing for the 2023 World Vaccine Congress
THERAPEUTIC
Exclusive interview with Dr Miguel Sanjuan
With just a few weeks left until the World Vaccine Congress we are looking forward to hearing from a range of speakers. One such speaker is Dr Miguel Sanjuan
European biotechs receive EUREKA therapeutic funding
In September 2022 LABIOTECH.EU announced that a partnership between European biotech companies had been awarded a €1.06 million grant from EUREKA Eurostars.
mRNA giants launch therapeutic protein ambitions
Published in Nature in September 2022, Ken Garber explores the hopes of mRNA companies who are setting their sights back on therapeutic proteins.
Holding out hope: a therapeutic prostate cancer vaccine
In Nature in September 2022 an article by Anthony King identified the difficulties associated with creating an immunotherapy for prostate tumours
Genexine announces DNA vaccine for cervical cancer
Genexine, a Korean biopharmaceutical company, announced in August that its “first-in-class proprietary DNA vaccine” demonstrated efficacy and safety
TECHNOLOGY
Sabin announces further BARDA funding for trials
In September 2022 the Sabin Vaccine Institute announced that it was “receiving an additional $21.8 million” from the BARDA in the US.
White paper from SGS: vaccine development post-pandemic
In a white paper from SGS in September 2022 the importance of “analytical biosafety testing” and “advances in developing scientific technologies” was emphasised
Biden declares pandemic over, sends shares plummeting
In September 2022 Biden declared in a 60 Minutes broadcast that the “pandemic is over”. Despite acknowledging that “we still have a problem” with COVID-19
World Vaccine Congress Europe 2022: meet our start-ups!
In its 23rd year the World Vaccine Congress Europe is set to be one of our biggest and most exciting events. We will be bringing experts from the value chain
HHS announces $20 million contract for faster distribution
In September the US HHS announced it was “significantly expanding the number of locations nationwide that can be supported with direct federal shipments”.
INFECTION
Immune imprinting: a help or a hindrance?
In an interview for the Human Vaccines Project in September 2022, Kristen Jill Abboud spoke to Professor Deepta Bhattacharya
Exclusive interview with Dr Charlie Weller
Here at the World Vaccine Congress, we are looking forward to our next event in Barcelona in October 2022. Speaking at the Congress will be Dr Charlie Weller.
WHO announces 2023 influenza vaccine recommendation
In September 2022 the WHO announced its recommendation for the viral composition of influenza vaccines for the 2023 southern hemisphere influenza season.
Long Covid: more questions than answers, studies suggest
An article by Gavi in September 2022 explored the few studies that investigate the links between COVID-19 vaccination and Long Covid.
Uganda declares Ebola outbreak of ‘Sudan’ strain
In September 2022 the WHO announced that health authorities in Uganda had declared an outbreak of Ebola. This follows a case of the Sudan ebolavirus
GLOBAL HEALTH
Global Fund Partners announce record funding against disease
In September the US hosted a “pledging conference” for the Global Fund to Fight AIDS, Tuberculosis, and Malaria. This raised a total of more than $14.25 billion
CEPI launches funding for Rift Valley fever trials
In September 2022 CEPI announced the launch of its second phase of funding to “advance innovative Rift Valley fever vaccine programmes into clinical trials”.
Fauci’s warning: politics disrupts childhood immunisation
Dr Anthony Fauci warned that tension caused by the politicisation of the COVID-19 vaccination programme could affect routine childhood immunisations.
Marking WHO’s World Patient Safety Day 2022
On September 17th the WHO marks World Patient Safety Day: safe maternal and new-born care. The World Health Assembly established World Patient Safety Day
COVID marathon end in sight, says WHO Director General
The WHO Director General reflected in his weekly press conference in early September that the end of the COVID-19 pandemic might be in sight.
